Marcus Wilson, Pharm.D., is president of HealthCore, WellPoint’s health outcomes research subsidiary located in Wilmington, Delaware. HealthCore provide research services and products focused on clinical effectiveness, health economics and safety of various healthcare interventions. The results of the studies offer insight to health care decision-makers to support clinical decision making, healthcare coverage decisions, evidence-based medical policy, process improvement and regulatory decisions.

Dr. Wilson received his doctor of pharmacy degree from VCU/Medical College of Virginia and joined the faculty of the University of Sciences in Philadelphia after completing his residency. While on the University of the Sciences in Philadelphia faculty, he developed an outcomes research and patient education division within the HealthCare Centers of Christiana, a wholly-owned division of Blue Cross Blue Shield of Delaware (BCBSD). The program assets were later purchased from BCBSD and used to found HealthCore. Much of his work has focused upon assessing the value (benefit versus cost) and safety of various healthcare products, services and programs including pharmaceuticals, biotechnologies, medical devices and disease management programs in the real world setting.

In addition to his leadership position with HealthCore, he also serves on several key WellPoint committees including the Strategy & Innovations Council, the Information Management Steering Committee and the Public Policy Steering Committee. He is a past member of the board of directors of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR) and is a reviewer for multiple journals and on the editorial board of Disease Management & Health Outcomes. His publications, including book chapters, span various clinical and health outcomes topics.

.

.

.